About Deep Genomics
Deep Genomics is at the forefront of revolutionizing drug development through the power of artificial intelligence. We utilize a sophisticated AI platform that efficiently analyzes RNA biology to uncover novel therapeutic targets. With a strong focus on RNA as a therapeutic modality, our proprietary AI, BigRNA, has been designed to facilitate breakthrough discoveries in drug development, tapping into the complexities and vastness of RNA data.
Founded in 2014, our team comprises over 100 dedicated professionals with expertise across various domains, including AI, molecular biology, automation, and clinical development. The application of our technology promises to transform how genetic conditions are treated, as we work relentlessly to discover and develop RNA-targeted therapies that can potentially address a wide array of genetic diseases. As we continue to expand and evolve, our commitment to innovation and excellence in the biotechnology sector remains unwavering.
FAQs
- When was Deep Genomics founded?
- Deep Genomics was founded in 2014.
- Who is the CEO of Deep Genomics?
- Brian O'Callaghan is the CEO.
- What industries or markets does Deep Genomics operate in?
- Deep Genomics operates in the following markets: Pharmaceutical, Biotechnology, Artificial Intelligence, Drug Development, RNA Therapeutics, Genetic Medicine, Healthcare Technology, Molecular Biology, Clinical Development, and Precision Medicine.
- How many employees does Deep Genomics have?
- Deep Genomics has 51-200 employees.
- Where does Deep Genomics have employees?
- Deep Genomics has employees in Canada.
- Does Deep Genomics support remote work or working from home?
- Yes, Deep Genomics is a remote-friendly company.
- Does Deep Genomics offer a four-day work week?
- No, Deep Genomics does not offer a four-day work week.
- What is Deep Genomics's website?
- Deep Genomics's website is www.deepgenomics.com.
Canada
